BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for both BNP Paribas and Exane, thanks to the strong collaboration and longstanding commitments from the teams of both firms.
Leveraging Exane’s expertise in cash equities (execution and research) and derivatives, BNP Paribas will be able to provide a full suite of services on equities to Institutional investors and Corporates worldwide, positioning the bank as a leading provider in Global Equities.
Merci pour votre vote !
Vous pouvez ajouter un commentaire (optionnel).
Dites-nous en plus (optionnel) :